FIBO Announcement

WNBF Pro Figure Champion Chrissy Zmijewski FIBO 2017 AnnouncementThe WNBF is excited to announce our participation in FIBO! This April 6-9, the largest and best attended health and fitness expo in the world will take place in Cologne, Germany.

FIBO POWER itself is expanding for 2017 with more exhibitors, more businesses, and more topics as it is Europe’s biggest meeting point for the bodybuilding, weight training, and martial arts communities.

The World Natural Bodybuilding Federation will be in attendance at Booth #L29 Hall 10.1 along with several of our international affiliates including:

  • NBFI (Natural Bodybuilding Federation of Italy)
  • UKDFBA (United Kingdom Drug-Free Bodybuilding Association)
  • SNBF (Swiss Natural Bodybuilding Federation)
  • DFNA (Danish Federation of Natural Athletes)
  • China (WNBF China)
  • SpainWNBF Pro Bodybuilder Rich Gozdecki

Drug testing policies and procedures, judging criteria for specific competitive categories, the 2017 world calendar of events, and other information will be available at our event booth.

Additionally, WNBF representatives and WNBF Professional athletes will be available to conduct short lectures about the history of the WNBF, our mission as a drug-free outlet for athletes, question and answer segments with WNBF Pro’s, posing presentations, and information for other potential event affiliates.

Join us at this great event, and stand with the WNBF as the largest, most respected, and fastest growing drug free bodybuilding & physique organization!

Featured are WNBF Professional Athletes Chrissy Zmijewski and Richard Gozdecki.

 

FIBO 2017 WNBF Vendor FIBO Power

 

WNBF Participation in FIBO Cologne Germany 2017

 

2017-05-17T23:18:45+00:00

About the Author:

An athlete since high school, Bob started bodybuilding in 1997, achieving WNBF Pro status in 2000. His degree in Exercise Physiology and leadership and event promotion skills lend professional experience in his role as WNBF Vice President in charge of the organization's stringent drug-testing policies.